Scandinavian Enviro Systems places 10,000,000 shares with Alumni Capital for SEK 0.75 million under financing deal
Bitget2026/10/06 13:28Scandinavian Enviro Systems set a directed share issue to Alumni Capital for 10,000,000 shares at SEK 0.07479. Transaction to raise about SEK 0.75 million before costs under an existing equity-based investment agreement. Also issued 520,731 warrants free of charge; each allows subscription for one share at SEK 0.22 through May 22, 2030. Share issue implies about 0.79% dilution; full warrant exercise adds about 0.04% dilution. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scandinavian Enviro Systems AB published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
- Scandinavian Enviro Systems set a directed share issue to Alumni Capital for 10,000,000 shares at SEK 0.07479.
- Transaction to raise about SEK 0.75 million before costs under an existing equity-based investment agreement.
- Also issued 520,731 warrants free of charge; each allows subscription for one share at SEK 0.22 through May 22, 2030.
- Share issue implies about 0.79% dilution; full warrant exercise adds about 0.04% dilution.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.